Hims & Hers Health, Inc. (HIMS) Free Cash Flow CAGR:-67.96%(TTM)
The free cash flow cagr for Hims & Hers Health, Inc. (HIMS) is -67.96% over the latest trailing 12-month period. Free cash flow CAGR uses precomputed cash-flow statement history.
The free cash flow CAGR for Hims & Hers Health, Inc. (HIMS) stock is -67.96% over the past 12 months. Free cash flow CAGR measures how Hims & Hers Health, Inc.'s cash generation has grown. FCF represents the cash available for dividends, buybacks, debt reduction, or reinvestment.
HIMS Free Cash Flow CAGR Chart
Hims & Hers Health, Inc. (HIMS)
HIMS Free Cash Flow CAGR History
| Year | Start FCF | End FCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $198.33M | $73.96M | $-124.37M | -62.71% | -62.71% |
| 2024 | $46.99M | $198.33M | +$151.34M | +322.07% | +322.07% |
| 2023 | $-33.78M | $46.99M | +$80.77M | +0.00% | N/A |
| 2022 | $-39.42M | $-33.78M | +$5.64M | +0.00% | N/A |
| 2021 | $-6.71M | $-39.42M | $-32.71M | +0.00% | N/A |
| 2020 | $-76.65M | $-6.71M | +$69.94M | +0.00% | N/A |
Quarterly Free Cash Flow — QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $53.03M | +6359.4% | +6.0% |
| Q4 2025 | $821,000 | -99.1% | -98.6% |
| Q3 2025 | $91.42M | +231.7% | +15.2% |
| Q2 2025 | -$69.43M | -238.7% | -246.0% |
| Q1 2025 | $50.05M | -15.9% | +321.3% |
| Q4 2024 | $59.50M | -25.0% | +451.7% |
| Q3 2024 | $79.39M | +66.9% | +311.9% |
| Q2 2024 | $47.57M | +300.4% | +377.5% |
| Q1 2024 | $11.88M | +10.2% | +70.4% |
| Q4 2023 | $10.79M | -44.0% | +215.6% |
| Q3 2023 | $19.27M | +93.4% | +378.9% |
| Q2 2023 | $9.96M | +42.9% | +228.2% |
| Q1 2023 | $6.97M | +174.7% | +133.7% |
| Q4 2022 | -$9.33M | -331.9% | -103.3% |
| Q3 2022 | $4.02M | +151.8% | +123.0% |
| Q2 2022 | -$7.77M | +62.5% | -1310.2% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum